WallStreetZenWallStreetZen

NASDAQ: HALO
Halozyme Therapeutics Inc Stock Ownership - Who owns Halozyme Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Halozyme Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Helen TorleyCEO;Pres2026-10-083,090$108.91
$336.53kSell
Helen TorleyCEO;Pres2026-10-0811,900$110.00
$1.31MSell
Helen TorleyCEO;Pres2026-10-084,810$108.18
$520.34kSell
Helen TorleyCEO;Pres2026-10-0820,000$18.41
$368.20kBuy
Helen TorleyCEO;Pres2026-10-08200$110.51
$22.10kSell
Helen TorleyCEO;Pres2026-10-0720,000$18.41
$368.20kBuy
Helen TorleyCEO;Pres2026-10-07200$113.69
$22.74kSell
Helen TorleyCEO;Pres2026-10-078,600$111.03
$954.87kSell
Helen TorleyCEO;Pres2026-10-0710,300$111.84
$1.15MSell
Helen TorleyCEO;Pres2026-10-07900$112.78
$101.50kSell

1 of 15

HALO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when HALO insiders and whales buy or sell their stock.

HALO Shareholders

What type of owners hold Halozyme Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Randal J. Kirk23.36%26,633,924$2.71BInsider
Gregory Ian Frost3.19%3,641,380$370.26MInsider
Helen Torley0.67%767,780$78.07MInsider
Jonathan E. Lim0.62%710,000$72.19MInsider
John Stuart Patton0.36%412,706$41.96MInsider
Kathryn E. Falberg0.31%358,253$36.43MInsider
Robert Engler0.24%273,176$27.78MInsider
Connie Matsui0.16%183,035$18.61MInsider
Kenneth J. Kelley0.16%179,833$18.29MInsider
Michael J. Labarre0.15%173,756$17.67MInsider

1 of 3

HALO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HALO0.11%30.09%Net SellingNet Selling
TECH0.11%2.56%Net SellingNet Selling
BMRN0.10%1.80%Net SellingNet Selling
SMMT0.01%99.99%Net Buying
KYMR0.11%31.12%Net SellingNet Selling
View Top Biotech Stocks

Halozyme Therapeutics Stock Ownership FAQ

Who owns Halozyme Therapeutics?

Halozyme Therapeutics (NASDAQ: HALO) is owned by 0.11% institutional shareholders, 30.09% Halozyme Therapeutics insiders, and 69.80% retail investors. Randal J. Kirk is the largest individual Halozyme Therapeutics shareholder, owning 26.63M shares representing 23.36% of the company. Randal J. Kirk's Halozyme Therapeutics shares are currently valued at $2.68B.

If you're new to stock investing, here's how to buy Halozyme Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.